tradingkey.logo
검색
시장
뉴스
분석
도구
종목 스크리너
더 알아보기
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
검색

Collplant Biotechnologies Ltd

CLGN
관심 목록에 추가
0.440USD
+0.020+4.79%
종가 05/15, 16:00（ET）시세는 15분 지연됩니다
6.34M시가총액
손실P/E TTM

Collplant Biotechnologies Ltd

0.440
+0.020+4.79%
개요금융토론분석회사

개요

금융

토론

분석

회사

자세한 내용은 Collplant Biotechnologies Ltd 회사

CollPlant Biotechnologies Ltd, formerly known as Collplant Holdings Ltd, is a company dealing in aesthetic medicine and regenerative medicine based in Israel. The company provides products and technologies for broadly understood regenerative medicine, including tissue regeneration and organ production. The technology is based on plants and is based on the production of collagen type I (rhCollagen).

Collplant Biotechnologies Ltd 정보

종목 코드 CLGN
회사 이름Collplant Biotechnologies Ltd
상장일Sep 01, 1993
CEORotem (Eran)
직원 수57
유형Ordinary Share
회계 연도 종료Sep 01
주소4 Oppenheimer Street
도시REHOVOT
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가Israel
우편 번호7670104
전화972732325600
웹사이트https://www.collplant.com
종목 코드 CLGN
상장일Sep 01, 1993
CEORotem (Eran)

Collplant Biotechnologies Ltd의 회사 임원진

이름
이름/직위
직위
주식 보유
변동
Mr. Yehiel Tal
Mr. Yehiel Tal
Chief Executive Officer
Chief Executive Officer
56.14K
+44.53%
Mr. Eran Rotem, CPA
Mr. Eran Rotem, CPA
Deputy Chief Executive Officer, Chief Financial Officer
Deputy Chief Executive Officer, Chief Financial Officer
26.25K
--
Dr. Philippe David Bensimon
Dr. Philippe David Bensimon
Vice President - Regulatory Affairs and Quality Assurance
Vice President - Regulatory Affairs and Quality Assurance
15.13K
+86.78%
Dr. Abraham (Avri) Havron, Ph.D.
Dr. Abraham (Avri) Havron, Ph.D.
Independent Director
Independent Director
3.13K
--
Mr. Joseph Zarzewsky
Mr. Joseph Zarzewsky
Independent Director
Independent Director
3.13K
--
Ms. Alisa Lask
Ms. Alisa Lask
Independent Director
Independent Director
3.13K
--
Dr. Oded Shoseyov, Ph.D.
Dr. Oded Shoseyov, Ph.D.
Founder, Chief Scientist
Founder, Chief Scientist
--
--
Dr. Nadav Orr
Dr. Nadav Orr
Vice President - Research & Development
Vice President - Research & Development
--
--
Dr. Ilana Belzer, Ph.D.
Dr. Ilana Belzer, Ph.D.
Chief Operating Officer
Chief Operating Officer
--
--
Dr. Gili Hart
Dr. Gili Hart
Independent Director
Independent Director
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. Yehiel Tal
Mr. Yehiel Tal
Chief Executive Officer
Chief Executive Officer
56.14K
+44.53%
Mr. Eran Rotem, CPA
Mr. Eran Rotem, CPA
Deputy Chief Executive Officer, Chief Financial Officer
Deputy Chief Executive Officer, Chief Financial Officer
26.25K
--
Dr. Philippe David Bensimon
Dr. Philippe David Bensimon
Vice President - Regulatory Affairs and Quality Assurance
Vice President - Regulatory Affairs and Quality Assurance
15.13K
+86.78%
Dr. Abraham (Avri) Havron, Ph.D.
Dr. Abraham (Avri) Havron, Ph.D.
Independent Director
Independent Director
3.13K
--
Mr. Joseph Zarzewsky
Mr. Joseph Zarzewsky
Independent Director
Independent Director
3.13K
--
Ms. Alisa Lask
Ms. Alisa Lask
Independent Director
Independent Director
3.13K
--

수익 분석

통화: USD마지막 업데이트: Mon, Apr 6
통화: USD마지막 업데이트: Mon, Apr 6
FY2025
FY2025Q2
FY2024
FY2024Q2
FY2023
FY2023Q2
FY2022
FY2022Q2
FY2021
FY2020
FY2019
사업별USD
이름
수익
비율
Revenues from licensing agreement
2.00M
84.35%
Revenues from the sales of goods
371.00K
15.65%
지역별USD
이름
수익
비율
United States
2.18M
91.78%
Europe
98.00K
4.13%
Canada
96.00K
4.05%
Israel
1.00K
0.04%
사업별
지역별
사업별USD
이름
수익
비율
Revenues from licensing agreement
2.00M
84.35%
Revenues from the sales of goods
371.00K
15.65%

주식 보유 통계

마지막 업데이트: Sat, May 9
마지막 업데이트: Sat, May 9
주주
주주 유형
주주
주주
비율
Sagy (Ami)
11.36%
Loewenbaum (George Walter II)
8.71%
St. Denis J. Villere & Company, LLC
4.21%
Pinnacle Associates Ltd.
3.82%
Loewenbaum (Lilian Shaw)
2.82%
기타
69.08%
주주
주주
비율
Sagy (Ami)
11.36%
Loewenbaum (George Walter II)
8.71%
St. Denis J. Villere & Company, LLC
4.21%
Pinnacle Associates Ltd.
3.82%
Loewenbaum (Lilian Shaw)
2.82%
기타
69.08%
주주 유형
주주
비율
Individual Investor
26.88%
Investment Advisor/Hedge Fund
4.72%
Investment Advisor
4.47%
Hedge Fund
1.51%
Research Firm
0.13%
Family Office
0.12%
Venture Capital
0.10%
Bank and Trust
0.01%
기타
62.05%

기관 주식 보유

마지막 업데이트: Wed, Apr 1
마지막 업데이트: Wed, Apr 1
보고 기간
기관 수
보유 주식
비율
변동
2026Q1
35
1.89M
13.14%
-218.89K
2025Q4
34
1.82M
18.05%
--
2025Q3
36
1.82M
18.09%
-351.44K
2025Q2
36
2.17M
13.51%
+569.42K
2025Q1
36
2.09M
19.82%
-180.41K
2024Q4
38
2.54M
24.36%
-57.22K
2024Q3
40
2.59M
23.16%
+143.75K
2024Q2
40
2.45M
24.33%
+72.69K
2024Q1
40
2.38M
24.25%
-401.71K
2023Q4
45
2.39M
26.23%
-101.34K
더 보기

주주 활동

이름
보유 주식
비율
변동
Chg %
날짜
Sagy (Ami)
1.64M
11.36%
-306.10K
-15.75%
Nov 19, 2025
Loewenbaum (George Walter II)
1.26M
8.71%
--
--
Nov 06, 2025
St. Denis J. Villere & Company, LLC
607.30K
4.21%
+18.58K
+3.16%
Dec 31, 2025
Pinnacle Associates Ltd.
557.19K
3.87%
+50.00K
+9.86%
Dec 31, 2025
Loewenbaum (Lilian Shaw)
406.29K
2.82%
-245.19K
-37.64%
Nov 06, 2025
Evans (Hugh M)
377.43K
2.62%
-1.00
-0.00%
Mar 15, 2025
AMH Equity, Ltd.
200.00K
1.39%
+39.15K
+24.34%
Sep 30, 2025
Brown Advisory
118.73K
0.82%
--
--
Dec 31, 2025
Pathstone
17.00K
0.12%
--
--
Dec 31, 2025
Tal (Yehiel)
31.14K
0.22%
--
--
Mar 15, 2025
더 보기

관련 ETF

이름
비율
데이터 없음

주식 배당금

지난 5년 동안 총 0.00 USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음

주식 분할

날짜
배당락일
유형
비율
데이터 없음
날짜
배당락일
유형
비율
데이터 없음
KeyAI